CT has been shown to restore sensitivity to TRAIL (tumor necrosis factor-related apoptosis inducing ligand) in a variety of cancer cells by inducing TRAIL receptor 2 (DR5) expression and TRAIL induced apoptosis in one study [67]. The gene discussed is TNFSF10; the disease is cancer.